Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$60.4 million.

  • Arcturus Therapeutics Holdings' Free Cash Flow rose 27.31% to -$17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.6 million, marking a year-over-year increase of 4.82%. This contributed to the annual value of -$60.4 million for FY2024, which is 187.60% down from last year.
  • Latest data reveals that Arcturus Therapeutics Holdings reported Free Cash Flow of -$60.4 million as of FY2024, which was down 187.60% from -$21.0 million recorded in FY2023.
  • In the past 5 years, Arcturus Therapeutics Holdings' Free Cash Flow ranged from a high of $24.3 million in FY2022 and a low of -$138.4 million during FY2021.
  • In the last 3 years, Arcturus Therapeutics Holdings' Free Cash Flow had a median value of -$21.0 million in 2023 and averaged -$19.0 million.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Free Cash Flow crashed by 514.11% in 2020 and then soared by 117.53% in 2022.
  • Arcturus Therapeutics Holdings' Free Cash Flow (Yearly) stood at -$44.6 million in 2020, then plummeted by 210.40% to -$138.4 million in 2021, then soared by 117.53% to $24.3 million in 2022, then crashed by 186.54% to -$21.0 million in 2023, then slumped by 187.60% to -$60.4 million in 2024.